Cargando…

Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells

Short noncoding endogenous RNAs, including microRNAs (miRNAs), are associated with the development and metastasis of multiple cancers. Epigallocatechin gallate (EGCG), the most active and abundant polyphenol in green tea, plays a crucial role in the modulation of miRNA expression, which is related t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chien-Hung, Wang, Hsin-Hui, Chen, Tsung-Hsien, Chiang, Ming-Chang, Hung, Peir-Haur, Chen, Yann-Jang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226234/ https://www.ncbi.nlm.nih.gov/pubmed/32326395 http://dx.doi.org/10.3390/cancers12040973

Ejemplares similares

Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines
por: Lin, Chien-Hung, et al.
Publicado: (2012)

CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation
por: Lin, Chien-Hung, et al.
Publicado: (2013)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells
por: Chan, Chi-Ming, et al.
Publicado: (2008)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Epigallocatechin-3-Gallate Reduces Hepatic Oxidative Stress and Lowers CYP-Mediated Bioactivation and Toxicity of Acetaminophen in Rats
por: Yao, Hsien-Tsung, et al.
Publicado: (2019)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo
por: Lin, Yu-Hsin, et al.
Publicado: (2014)

Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Hung, Peir-Haur, et al.
Publicado: (2021)

Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder
por: Chen, Tsung-Hsien, et al.
Publicado: (2023)

Effects of Epigallocatechin Gallate on the Stability of Epicatechin in a Photolytic Process
por: Huang, Shiuh-Tsuen, et al.
Publicado: (2019)

Protective effects of (-)-epigallocatechin-3-gallate against acetaminophen-induced liver injury in rats)
por: Yao, Hsien-Tsung, et al.
Publicado: (2015)

Inhibitory Effects of Epigallocatechin-3-Gallate on Microsomal Cyclooxygenase-1 Activity in Platelets
por: Lee, Dong-Ha, et al.
Publicado: (2013)

Inhibitory effects of epigallocatechin gallate and its glucoside on the human intestinal maltase inhibition
por: Nguyen, Thi Thanh Hanh, et al.
Publicado: (2012)

Plasma-Induced Oxidation Products of (–)-Epigallocatechin Gallate with Digestive Enzymes Inhibitory Effects
por: Jeong, Gyeong Han, et al.
Publicado: (2021)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2
por: ZHANG, WEIJUN, et al.
Publicado: (2014)

Reduction of 3-Deoxyglucosone by Epigallocatechin Gallate Results Partially from an Addition Reaction: The Possible Mechanism of Decreased 5-Hydroxymethylfurfural in Epigallocatechin Gallate-Treated Black Garlic
por: Tu, An-Ting, et al.
Publicado: (2021)

The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation
por: Hung, Peir-Haur, et al.
Publicado: (2022)

Selective Inhibitory Effect of Epigallocatechin-3-gallate on Migration of Vascular Smooth Muscle Cells
por: Han, Dong-Wook, et al.
Publicado: (2010)

Inhibitory Effect of Epigallocatechin Gallate-Silver Nanoparticles and Their Lysozyme Bioconjugates on Biofilm Formation and Cytotoxicity
por: Meesaragandla, Brahmaiah, et al.
Publicado: (2022)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Infections and risk of end-stage renal disease in patients with nephrotic syndrome: a nationwide population-based case-control study
por: Lin, Chien-Hung, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

Glycated Hemoglobin < 6.5% Is Associated With Uroseptic Shock in Diabetic Patients With Urinary Tract Infection
por: Lee, Yi-Chien, et al.
Publicado: (2020)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer
por: Hung, Sze Wan, et al.
Publicado: (2022)

Proteomic analysis of the inhibitory effect of epigallocatechin gallate on lipid accumulation in human HepG2 cells
por: Liu, Zhonghua, et al.
Publicado: (2013)

Inhibitory Effect of (—)‐Epigallocatechin Gallate on Carcinogenesis with N‐Ethyl‐N′‐nitro‐N‐nitrosoguanidine in Mouse Duodenum
por: Fujita, Yoshihiro, et al.
Publicado: (1989)

In Vitro Growth- and Encystation-Inhibitory Efficacies of Matcha Green Tea and Epigallocatechin Gallate Against Acanthameoba Castellanii
por: Dickson, Ameliya, et al.
Publicado: (2020)

Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells
por: Li, Bin-Bin, et al.
Publicado: (2017)

Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017)

Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
por: Luo, Xin, et al.
Publicado: (2022)

MicroRNA-328 inhibits migration and epithelial–mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells
por: Lin, Chien-Hung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l00ne1k527ajgfnpf5ofshmri5